Amarin

40 results

Ryanair was one of the main movers in Dublin, gaining 3.3% on the back of numbers that show an 8% rise in passengers flown last month

European shares closed comfortably higher on Tuesday, with utilities and consumer stocks leading gains as investors brushed aside US president Donald (...)

Vascepa is aiming to become the first prescription drug for people at risk of stroke or heart attack who continue to have high levels of harmful blood fats despite being on treatment with statins

Shares in US-listed Irish biotech Amarin surged in New York after it upgraded its profit forecasts. A strong update for the prospects of its cardiova(...)

John Thero: ‘I am pleased that Amarin’s significant progress and innovative work is recognised by this award.’ Photograph: Cyril Byrne

Fish oil drug specialist Amarin has been recognised for the breakthrough results for its one medicine, Vascepa, as a cardiovascular therapy. John The(...)

The FDA grants priority review only to drugs that have the potential to offer significant improvement in the treatment of serious conditions.

Shares in Irish drug company Amarin jumped 14 per cent after its Vascepa drug was fast-tracked for approval as a treatment for reducing the risk of he(...)

Finlay McFadyen, head of investment banking, AIB Group; Fountain Healthcare partner Dr Manus Rogan; and Andrew McDowell, vice-president, European Investment Bank. Photograph: Nick Bradshaw

Irish life sciences venture capital group Fountain Healthcare Partners has raised €118 million in a new fund. The sum is well in excess of the €100 m(...)

US FDA approval would allow Amarin to pitch its fish-oil drug direct to the consumer rather than solely through the medical practitioner channel. File photograph: Getty

Shareholders tuning into Amarin’s annual shareholders’ meeting in Dublin on Monday had plenty to cheer them. Shares in the company have risen more th(...)

Amarin chief executive John Thero: ‘Our guidance is for 50 per cent greater growth over the prior year’

Irish drug company Amarin will seek European approval for its cardiovascular drug Vascepa before the end of the year. The drug is in the process of s(...)

Seamus Hand, KPMG managing partner, presents the Company of the Year award to Dermot Crowley and Stephen McNally, deputy CEOs at Dalata, at The Irish Times Business Awards on Wednesday. Photograph: Kieran Harnett

Dublin-listed Dalata has been named company of the year at The Irish Times Business Awards 2019 at a ceremony in the Mansion House on Wednesday. Fou(...)

Stripe founders Patrick and John Collison. The company’s valuation recently rose to €19.9 billion

In a troublesome geo-political environment, business was at times a struggle in the past 12 months. But the cream eventually rises to the top and our (...)

Aryzta had an unremitting bad year and was the  standout corporate loser of 2018. Photograph: Reuters

It was another year of mixed fortunes in corporate Ireland. The economy continues to be the fastest growing in Europe while the live register fell to (...)

  • 1
  • 2
  • 3
  • 4
  • Next
  • Last »